Private Capital Advisors Inc. purchased a new position in shares of Amrize Ltd (NYSE:AMRZ – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 4,668 shares of the company’s stock, valued at approximately $233,000.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in AMRZ. Credit Industriel ET Commercial purchased a new position in shares of Amrize during the second quarter worth about $109,000. Cullen Frost Bankers Inc. purchased a new stake in Amrize in the 2nd quarter valued at approximately $244,000. Rockbridge Capital Management LLC purchased a new stake in Amrize in the 2nd quarter valued at approximately $1,996,000. Generali Asset Management SPA SGR purchased a new stake in Amrize in the 2nd quarter valued at approximately $4,923,000. Finally, TD Asset Management Inc purchased a new stake in Amrize in the 2nd quarter valued at approximately $8,190,000.
Amrize Price Performance
Shares of NYSE:AMRZ opened at $49.03 on Wednesday. The stock’s 50 day moving average price is $50.67. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.85 and a current ratio of 1.38. Amrize Ltd has a 12 month low of $44.12 and a 12 month high of $56.29.
Insider Activity
In related news, CEO Jan Philipp Jenisch acquired 545,000 shares of the business’s stock in a transaction that occurred on Monday, August 11th. The stock was purchased at an average cost of $47.96 per share, for a total transaction of $26,138,200.00. Following the transaction, the chief executive officer directly owned 1,450,000 shares of the company’s stock, valued at approximately $69,542,000. This trade represents a 60.22% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Ian A. Johnston acquired 10,500 shares of the business’s stock in a transaction that occurred on Friday, August 8th. The shares were bought at an average price of $47.71 per share, with a total value of $500,955.00. Following the completion of the transaction, the chief financial officer directly owned 17,344 shares in the company, valued at approximately $827,482.24. The trade was a 153.42% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 1,124,000 shares of company stock worth $53,225,260.
Analysts Set New Price Targets
AMRZ has been the topic of a number of analyst reports. Oppenheimer initiated coverage on Amrize in a report on Tuesday, September 9th. They issued an “outperform” rating and a $62.00 price objective on the stock. Zacks Research raised Amrize from a “strong sell” rating to a “hold” rating in a report on Friday, October 10th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Amrize in a report on Wednesday, October 8th. UBS Group lifted their price objective on Amrize from $49.00 to $52.00 and gave the company a “neutral” rating in a report on Tuesday, October 14th. Finally, JPMorgan Chase & Co. boosted their price target on Amrize from $52.00 to $60.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, Amrize currently has an average rating of “Moderate Buy” and an average target price of $57.50.
View Our Latest Stock Report on AMRZ
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Stories
- Five stocks we like better than Amrize
- Why Invest in 5G? How to Invest in 5G Stocks
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- With Risk Tolerance, One Size Does Not Fit All
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- Where Do I Find 52-Week Highs and Lows?
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
